Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster presentation 2

1042 - The prognosis of neck residue nasopharyngeal carcinoma (NPC) patients: Results from a case control study


20 Dec 2015


Poster presentation 2


Sai-Lan Liu


Annals of Oncology (2015) 26 (suppl_9): 93-102. 10.1093/annonc/mdv527


S. Liu, L. Tang, L. Guo, H. Mai

Author affiliations

  • Department Of Nasopharyngeal Carcinoma, Cancer Centre Sun Yat-Sen University, 510060 - Guangzhou/CN


Abstract 1042


Our study is to assess the prognosis of neck residue NPC patients and the efficacy of radical neck dissection in the treatment of these patients.


68 neck residue NPC patients were recruited. Each neck residue patient was matched to another three patients, adjusting for age(±5 years), gender, pathological type, T'N'M stage, RT technique and type of treatment from the same institute and time period of therapy (± 18 months). The primary endpoint was progression-free survival (PFS). Secondary endpoints were overall survival (OS), distant metastasis-free survival (DMFS), and locoregional relapse-free survival (LRRFS). The Cox proportional hazards model was used to calculate hazard ratios (HRs) with 95% confidence intervals (CIs) and in multivariable analysis to test the independent statistical significance of NPC patients. All statistical tests were two-sided.


With a median follow-up of 44 months, residual group significantly decreased the 3-year PFS rate(87.6% vs. 46.7%; HR of progression = 6.09, 95% CI = 3.66 to 10.14; P < 0.001), OS(92.8% vs. 85.3%; HR of death = 3.536, 95% CI = 1.78 to 7.04; P < 0.001), distant metastasis-free survival ( 90.4% vs.77.6%; HR of distant relapse = 3.21, 95% CI = 1.70 to 6.05; P < 0.001) and locoregional relapse-free survival rate (97.1% vs.54.1%; HR of locoregional relapse = 18.93, 95% CI = 8.19 to 43.78; P < 0.001). Multivariable analysis showed that neck residue was still an independent prognostic factor for PFS, OS, DMFS and LRRFS, respectively, after adjusting for other risk factors.


Neck residue after completely treatment was associated with poor prognosis for NPC patients. In addition of management of radical neck dissection, more intensive treatment should be provided for the patients with neck residue after completely chemoradiotherapy.

Clinical trial identification


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings